Komal Balani

Komal Balani, MS, RAC, currently serves as Senior Director of Regulatory Affairs at RAPT Therapeutics, a position held since January 2023. Prior to this role, Komal Balani held multiple senior positions at Kronos Bio, Inc. from September 2020 to January 2023, including Senior Director and Director of Regulatory Science. Earlier experience includes Senior Manager of Regulatory Science at Acerta Pharma from August 2018 to September 2020, and Senior Regulatory Affairs Associate roles at both Jazz Pharmaceuticals and Medivation between July 2016 and July 2016. Komal Balani began a career in regulatory affairs at Stanford Health Care and was previously a Research Associate Intern at Ranbaxy. Education includes a Master of Science in Regulatory Affairs from San Diego State University and an MS in Pharmaceutical Sciences from Manipal Academy of Higher Education.